Steve Valiquette
Stock Analyst at Barclays
(1.86)
# 3,124
Out of 4,905 analysts
175
Total ratings
45.61%
Success rate
-3.5%
Average return
Main Sectors:
Stocks Rated by Steve Valiquette
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BKD Brookdale Senior Living | Maintains: Equal-Weight | $7 → $7.5 | $7.71 | -2.72% | 4 | Apr 16, 2025 | |
| TDOC Teladoc Health | Maintains: Overweight | $10 → $12 | $8.05 | +49.07% | 13 | Oct 31, 2024 | |
| WBA Walgreens Boots Alliance | Maintains: Underweight | $7 → $8 | $11.49 | -30.37% | 15 | Oct 16, 2024 | |
| MCK McKesson | Maintains: Overweight | $596 → $616 | $709.80 | -13.21% | 6 | Aug 8, 2024 | |
| GDRX GoodRx Holdings | Maintains: Overweight | $8 → $9 | $4.68 | +92.31% | 7 | Mar 1, 2024 | |
| HOUS Anywhere Real Estate | Maintains: Underweight | $4.5 → $5 | $4.00 | +25.00% | 3 | Feb 20, 2024 | |
| MPW Medical Properties Trust | Maintains: Overweight | $12 → $10 | $4.08 | +145.10% | 5 | Aug 22, 2023 | |
| HR Healthcare Realty Trust | Maintains: Equal-Weight | $25 → $24 | $16.18 | +48.33% | 4 | Aug 11, 2023 | |
| CVS CVS Health | Maintains: Overweight | $89 → $86 | $61.96 | +38.80% | 14 | Aug 3, 2023 | |
| CNC Centene | Maintains: Overweight | $86 → $85 | $27.95 | +204.11% | 6 | Jul 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $275 → $300 | $361.12 | -16.93% | 4 | Jun 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $93 → $88 | $97.45 | -9.70% | 3 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $35 → $34 | $35.02 | -2.91% | 3 | May 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $70 → $105 | $175.06 | -40.02% | 3 | Apr 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $57 → $55 | $65.80 | -16.41% | 3 | Apr 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $15 → $13 | $18.07 | -28.06% | 11 | Apr 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $132 → $142 | $168.94 | -15.95% | 2 | Apr 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $13 → $5 | $24.71 | -79.77% | 4 | Apr 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $57 | $110.01 | -48.19% | 2 | Mar 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $78 → $82 | $159.05 | -48.44% | 5 | Jan 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $20 → $18 | $18.32 | -1.75% | 2 | Jan 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $33 → $31 | $37.94 | -18.29% | 2 | Jan 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $400 → $375 | $182.98 | +104.94% | 3 | Jan 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $20 → $19 | $30.34 | -37.38% | 2 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $500 → $570 | $220.41 | +158.61% | 4 | Jul 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $70 → $64 | $159.56 | -59.89% | 4 | May 26, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $275 → $310 | $295.71 | +4.83% | 16 | May 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $495 → $565 | $282.65 | +99.89% | 3 | Mar 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $150 → $75 | $5.78 | +1,197.58% | 4 | Nov 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $26 → $19 | $4.01 | +373.82% | 2 | Aug 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $6 → $10 | $3.59 | +178.55% | 10 | Aug 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $42 → $34 | $20.95 | +62.29% | 4 | May 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $20 | $3.97 | +404.41% | 1 | May 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Overweight | $260 | $109.33 | +137.81% | 1 | Feb 19, 2021 |
Brookdale Senior Living
Apr 16, 2025
Maintains: Equal-Weight
Price Target: $7 → $7.5
Current: $7.71
Upside: -2.72%
Teladoc Health
Oct 31, 2024
Maintains: Overweight
Price Target: $10 → $12
Current: $8.05
Upside: +49.07%
Walgreens Boots Alliance
Oct 16, 2024
Maintains: Underweight
Price Target: $7 → $8
Current: $11.49
Upside: -30.37%
McKesson
Aug 8, 2024
Maintains: Overweight
Price Target: $596 → $616
Current: $709.80
Upside: -13.21%
GoodRx Holdings
Mar 1, 2024
Maintains: Overweight
Price Target: $8 → $9
Current: $4.68
Upside: +92.31%
Anywhere Real Estate
Feb 20, 2024
Maintains: Underweight
Price Target: $4.5 → $5
Current: $4.00
Upside: +25.00%
Medical Properties Trust
Aug 22, 2023
Maintains: Overweight
Price Target: $12 → $10
Current: $4.08
Upside: +145.10%
Healthcare Realty Trust
Aug 11, 2023
Maintains: Equal-Weight
Price Target: $25 → $24
Current: $16.18
Upside: +48.33%
CVS Health
Aug 3, 2023
Maintains: Overweight
Price Target: $89 → $86
Current: $61.96
Upside: +38.80%
Centene
Jul 31, 2023
Maintains: Overweight
Price Target: $86 → $85
Current: $27.95
Upside: +204.11%
Jun 28, 2023
Maintains: Equal-Weight
Price Target: $275 → $300
Current: $361.12
Upside: -16.93%
May 5, 2023
Maintains: Equal-Weight
Price Target: $93 → $88
Current: $97.45
Upside: -9.70%
May 3, 2023
Maintains: Underweight
Price Target: $35 → $34
Current: $35.02
Upside: -2.91%
Apr 26, 2023
Maintains: Overweight
Price Target: $70 → $105
Current: $175.06
Upside: -40.02%
Apr 25, 2023
Maintains: Overweight
Price Target: $57 → $55
Current: $65.80
Upside: -16.41%
Apr 25, 2023
Maintains: Equal-Weight
Price Target: $15 → $13
Current: $18.07
Upside: -28.06%
Apr 25, 2023
Upgrades: Equal-Weight
Price Target: $132 → $142
Current: $168.94
Upside: -15.95%
Apr 5, 2023
Maintains: Underweight
Price Target: $13 → $5
Current: $24.71
Upside: -79.77%
Mar 14, 2023
Initiates: Equal-Weight
Price Target: $57
Current: $110.01
Upside: -48.19%
Jan 17, 2023
Maintains: Overweight
Price Target: $78 → $82
Current: $159.05
Upside: -48.44%
Jan 17, 2023
Maintains: Overweight
Price Target: $20 → $18
Current: $18.32
Upside: -1.75%
Jan 17, 2023
Maintains: Equal-Weight
Price Target: $33 → $31
Current: $37.94
Upside: -18.29%
Jan 4, 2023
Maintains: Overweight
Price Target: $400 → $375
Current: $182.98
Upside: +104.94%
Oct 21, 2022
Maintains: Equal-Weight
Price Target: $20 → $19
Current: $30.34
Upside: -37.38%
Jul 28, 2022
Maintains: Overweight
Price Target: $500 → $570
Current: $220.41
Upside: +158.61%
May 26, 2022
Downgrades: Equal-Weight
Price Target: $70 → $64
Current: $159.56
Upside: -59.89%
May 23, 2022
Maintains: Overweight
Price Target: $275 → $310
Current: $295.71
Upside: +4.83%
Mar 30, 2022
Maintains: Overweight
Price Target: $495 → $565
Current: $282.65
Upside: +99.89%
Nov 10, 2021
Downgrades: Equal-Weight
Price Target: $150 → $75
Current: $5.78
Upside: +1,197.58%
Aug 12, 2021
Upgrades: Overweight
Price Target: $26 → $19
Current: $4.01
Upside: +373.82%
Aug 3, 2021
Maintains: Underweight
Price Target: $6 → $10
Current: $3.59
Upside: +178.55%
May 28, 2021
Downgrades: Underweight
Price Target: $42 → $34
Current: $20.95
Upside: +62.29%
May 24, 2021
Initiates: Overweight
Price Target: $20
Current: $3.97
Upside: +404.41%
Feb 19, 2021
Reinstates: Overweight
Price Target: $260
Current: $109.33
Upside: +137.81%